_id
6913017fccc777a4e85d7930
Ticker
IMRX
Name
Immuneering Corp
Exchange
NASDAQ
Address
245 Main Street, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://immuneering.com
Description
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Last Close
6.2
Volume
457937
Current Price
6.185
Change
-0.2419354838709769
Last Updated
2025-12-01T09:19:05.175Z
Image
data:image/webp;base64,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
Ipo Date
2021-07-30T00:00:00.000Z
Market Cap
494605952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99275
Sentiment Sources
4
Rating
4.2
Target Price
16.8333
Strong Buy
2
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
86158
Gross Profit
-86158
Operating Expenses
15294548
Operating Income
-15380706
Interest Expense
-
Pretax Income
-14964875
Net Income
-14964875
Eps
-0.377233152580048
Dividends Per Share
-
Shares Outstanding
64569967
Income Tax Expense
-
EBITDA
-14878717
Operating Margin
-
Total Other Income Expense Net
415831
Cash
227563077
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
229101829
Property Plant Equipment
4304246
Total Assets
241056266
Payables
1600274
Short Term Debt
381760
Long Term Debt
-
Total Liabilities
13079834
Equity
227976432
Depreciation
86158
Change In Working Capital
1358130
Cash From Operations
-11977235
Capital Expenditures
7255
Cash From Investing
-7255
Cash From Financing
213192069
Net Change In Cash
201207579
PE
-
PB
1.0762495729163792
ROE
-6.564220199744156
ROA
-6.208042316560234
FCF
-11984490
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
86158
Quarters > 0 > income Statement > gross Profit
-86158
Quarters > 0 > income Statement > operating Expenses
15294548
Quarters > 0 > income Statement > operating Income
-15380706
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-14964875
Quarters > 0 > income Statement > net Income
-14964875
Quarters > 0 > income Statement > eps
-0.377233152580048
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
39670095
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-14878717
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
415831
Quarters > 0 > balance Sheet > cash
227563077
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
229101829
Quarters > 0 > balance Sheet > property Plant Equipment
4304246
Quarters > 0 > balance Sheet > total Assets
241056266
Quarters > 0 > balance Sheet > payables
1600274
Quarters > 0 > balance Sheet > short Term Debt
381760
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13079834
Quarters > 0 > balance Sheet > equity
227976432
Quarters > 0 > cash Flow > net Income
-14964875
Quarters > 0 > cash Flow > depreciation
86158
Quarters > 0 > cash Flow > change In Working Capital
1358130
Quarters > 0 > cash Flow > cash From Operations
-11977235
Quarters > 0 > cash Flow > capital Expenditures
7255
Quarters > 0 > cash Flow > cash From Investing
-7255
Quarters > 0 > cash Flow > cash From Financing
213192069
Quarters > 0 > cash Flow > net Change In Cash
201207579
Quarters > 0 > ratios > PE
-0.377233152580048
Quarters > 0 > ratios > PB
1.0762495729163792
Quarters > 0 > ratios > ROE
-6.564220199744156
Quarters > 0 > ratios > ROA
-6.208042316560234
Quarters > 0 > ratios > FCF
-11984490
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
91844
Quarters > 1 > income Statement > gross Profit
-91844
Quarters > 1 > income Statement > operating Expenses
14757894
Quarters > 1 > income Statement > operating Income
-14757894
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-14433464
Quarters > 1 > income Statement > net Income
-14433881
Quarters > 1 > income Statement > eps
-0.40109848090965017
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
35985878
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-14665634
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
324430
Quarters > 1 > balance Sheet > cash
26355498
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
27725426
Quarters > 1 > balance Sheet > property Plant Equipment
4463105
Quarters > 1 > balance Sheet > total Assets
40056468
Quarters > 1 > balance Sheet > payables
2395203
Quarters > 1 > balance Sheet > short Term Debt
366959
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
11120431
Quarters > 1 > balance Sheet > equity
28936037
Quarters > 1 > cash Flow > net Income
-14433880
Quarters > 1 > cash Flow > depreciation
91843
Quarters > 1 > cash Flow > change In Working Capital
3285767
Quarters > 1 > cash Flow > cash From Operations
-9446124
Quarters > 1 > cash Flow > capital Expenditures
2116
Quarters > 1 > cash Flow > cash From Investing
-2116
Quarters > 1 > cash Flow > cash From Financing
-61958
Quarters > 1 > cash Flow > net Change In Cash
-9510198
Quarters > 1 > ratios > PE
-0.40109848090965017
Quarters > 1 > ratios > PB
7.691884532425777
Quarters > 1 > ratios > ROE
-49.88202427305439
Quarters > 1 > ratios > ROA
-36.03383353719554
Quarters > 1 > ratios > FCF
-9448240
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
175761
Quarters > 2 > income Statement > gross Profit
-175761
Quarters > 2 > income Statement > operating Expenses
15484652
Quarters > 2 > income Statement > operating Income
-15484652
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-15046490
Quarters > 2 > income Statement > net Income
-15046132
Quarters > 2 > income Statement > eps
-0.42348098427758313
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35529652
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15392432
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
438162
Quarters > 2 > balance Sheet > cash
35865696
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
38206155
Quarters > 2 > balance Sheet > property Plant Equipment
4630719
Quarters > 2 > balance Sheet > total Assets
50681297
Quarters > 2 > balance Sheet > payables
1310565
Quarters > 2 > balance Sheet > short Term Debt
352521
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8838377
Quarters > 2 > balance Sheet > equity
41842920
Quarters > 2 > cash Flow > net Income
-15046132
Quarters > 2 > cash Flow > depreciation
92578
Quarters > 2 > cash Flow > change In Working Capital
-902534
Quarters > 2 > cash Flow > cash From Operations
-14080638
Quarters > 2 > cash Flow > capital Expenditures
8945
Quarters > 2 > cash Flow > cash From Investing
-8945
Quarters > 2 > cash Flow > cash From Financing
13810559
Quarters > 2 > cash Flow > net Change In Cash
-279024
Quarters > 2 > ratios > PE
-0.42348098427758313
Quarters > 2 > ratios > PB
5.251805983425631
Quarters > 2 > ratios > ROE
-35.95860900721078
Quarters > 2 > ratios > ROA
-29.68774062747447
Quarters > 2 > ratios > FCF
-14089583
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
726326
Quarters > 3 > income Statement > cost Of Revenue
174645
Quarters > 3 > income Statement > gross Profit
-174645
Quarters > 3 > income Statement > operating Expenses
18383510
Quarters > 3 > income Statement > operating Income
-18558155
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-18051485
Quarters > 3 > income Statement > net Income
-18051485
Quarters > 3 > income Statement > eps
-0.5813598889136801
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31050448
Quarters > 3 > income Statement > income Tax Expense
328
Quarters > 3 > income Statement > EBITDA
-17876840
Quarters > 3 > income Statement > operating Margin
-2555.0723779680197
Quarters > 3 > income Statement > total Other Income Expense Net
506670
Quarters > 3 > balance Sheet > cash
36144720
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
39587569
Quarters > 3 > balance Sheet > property Plant Equipment
4790217
Quarters > 3 > balance Sheet > total Assets
52714413
Quarters > 3 > balance Sheet > payables
1958536
Quarters > 3 > balance Sheet > short Term Debt
338438
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
11328187
Quarters > 3 > balance Sheet > equity
41386226
Quarters > 3 > cash Flow > net Income
-18051485
Quarters > 3 > cash Flow > depreciation
174645
Quarters > 3 > cash Flow > change In Working Capital
1691805
Quarters > 3 > cash Flow > cash From Operations
-14510513
Quarters > 3 > cash Flow > capital Expenditures
9357
Quarters > 3 > cash Flow > cash From Investing
5490644
Quarters > 3 > cash Flow > cash From Financing
-40988
Quarters > 3 > cash Flow > net Change In Cash
-9060857
Quarters > 3 > ratios > PE
-0.5813598889136801
Quarters > 3 > ratios > PB
4.640360802166402
Quarters > 3 > ratios > ROE
-43.61713242468642
Quarters > 3 > ratios > ROA
-34.243926798539896
Quarters > 3 > ratios > FCF
-14519870
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-19.99084433160867
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
713451
Annuals > 0 > income Statement > gross Profit
-713451
Annuals > 0 > income Statement > operating Expenses
64071401
Annuals > 0 > income Statement > operating Income
-64071401
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-61036862
Annuals > 0 > income Statement > net Income
-61036608
Annuals > 0 > income Statement > eps
-2.0358046019278846
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29981565
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-63686581
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3034539
Annuals > 0 > balance Sheet > cash
36144720
Annuals > 0 > balance Sheet > short Term Investments
-36108575280
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
39587569
Annuals > 0 > balance Sheet > property Plant Equipment
4790217
Annuals > 0 > balance Sheet > total Assets
52714413
Annuals > 0 > balance Sheet > payables
1958536
Annuals > 0 > balance Sheet > short Term Debt
338438
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11328187
Annuals > 0 > balance Sheet > equity
41386226
Annuals > 0 > cash Flow > net Income
-61036608
Annuals > 0 > cash Flow > depreciation
385074
Annuals > 0 > cash Flow > change In Working Capital
-925383
Annuals > 0 > cash Flow > cash From Operations
-54999571
Annuals > 0 > cash Flow > capital Expenditures
84875
Annuals > 0 > cash Flow > cash From Investing
26434955
Annuals > 0 > cash Flow > cash From Financing
5303519
Annuals > 0 > cash Flow > net Change In Cash
-23261097
Annuals > 0 > ratios > PE
-2.0358046019278846
Annuals > 0 > ratios > PB
5.549159952395756
Annuals > 0 > ratios > ROE
-147.48048783186945
Annuals > 0 > ratios > ROA
-115.78732366800708
Annuals > 0 > ratios > FCF
-55084446
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
455
Annuals > 1 > income Statement > cost Of Revenue
764138
Annuals > 1 > income Statement > gross Profit
-764138
Annuals > 1 > income Statement > operating Expenses
58412887
Annuals > 1 > income Statement > operating Income
-58412887
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-53472020
Annuals > 1 > income Statement > net Income
-53471622
Annuals > 1 > income Statement > eps
-1.8817065036518497
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
28416558
Annuals > 1 > income Statement > income Tax Expense
2
Annuals > 1 > income Statement > EBITDA
-58061202
Annuals > 1 > income Statement > operating Margin
-12837997.142857144
Annuals > 1 > income Statement > total Other Income Expense Net
4940867
Annuals > 1 > balance Sheet > cash
59405817
Annuals > 1 > balance Sheet > short Term Investments
26259868
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
89083669
Annuals > 1 > balance Sheet > property Plant Equipment
5396312
Annuals > 1 > balance Sheet > total Assets
102584538
Annuals > 1 > balance Sheet > payables
2111666
Annuals > 1 > balance Sheet > short Term Debt
300107
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
12008355
Annuals > 1 > balance Sheet > equity
90576183
Annuals > 1 > cash Flow > net Income
-53471622
Annuals > 1 > cash Flow > depreciation
352083
Annuals > 1 > cash Flow > change In Working Capital
-974641
Annuals > 1 > cash Flow > cash From Operations
-48968634
Annuals > 1 > cash Flow > capital Expenditures
342746
Annuals > 1 > cash Flow > cash From Investing
7296492
Annuals > 1 > cash Flow > cash From Financing
28441073
Annuals > 1 > cash Flow > net Change In Cash
-13231069
Annuals > 1 > ratios > PE
-1.8817065036518497
Annuals > 1 > ratios > PB
2.4031795894953976
Annuals > 1 > ratios > ROE
-59.034969490820785
Annuals > 1 > ratios > ROA
-52.12444588871668
Annuals > 1 > ratios > FCF
-49311380
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-108376.65934065935
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
316952
Annuals > 2 > income Statement > cost Of Revenue
158122
Annuals > 2 > income Statement > gross Profit
158830
Annuals > 2 > income Statement > operating Expenses
51903698
Annuals > 2 > income Statement > operating Income
-51744868
Annuals > 2 > income Statement > interest Expense
1014456
Annuals > 2 > income Statement > pretax Income
-50514039
Annuals > 2 > income Statement > net Income
-50513568
Annuals > 2 > income Statement > eps
-1.9143452590652683
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
26386864
Annuals > 2 > income Statement > income Tax Expense
-1231771
Annuals > 2 > income Statement > EBITDA
-51468087
Annuals > 2 > income Statement > operating Margin
-16325.774249728664
Annuals > 2 > income Statement > total Other Income Expense Net
1230829
Annuals > 2 > balance Sheet > cash
72636886
Annuals > 2 > balance Sheet > short Term Investments
32887970
Annuals > 2 > balance Sheet > receivables
12417
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
108746809
Annuals > 2 > balance Sheet > property Plant Equipment
5777393
Annuals > 2 > balance Sheet > total Assets
122367283
Annuals > 2 > balance Sheet > payables
3154557
Annuals > 2 > balance Sheet > short Term Debt
378723
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
12517028
Annuals > 2 > balance Sheet > equity
109850255
Annuals > 2 > cash Flow > net Income
-50513568
Annuals > 2 > cash Flow > depreciation
796793
Annuals > 2 > cash Flow > change In Working Capital
1717276
Annuals > 2 > cash Flow > cash From Operations
-44101265
Annuals > 2 > cash Flow > capital Expenditures
742485
Annuals > 2 > cash Flow > cash From Investing
41831002
Annuals > 2 > cash Flow > cash From Financing
19004
Annuals > 2 > cash Flow > net Change In Cash
-2251259
Annuals > 2 > ratios > PE
-1.9143452590652683
Annuals > 2 > ratios > PB
1.8399900686621073
Annuals > 2 > ratios > ROE
-45.984024342956694
Annuals > 2 > ratios > ROA
-41.28028894782276
Annuals > 2 > ratios > FCF
-44843750
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-141.48435725283323
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2079961
Annuals > 3 > income Statement > cost Of Revenue
1153073
Annuals > 3 > income Statement > gross Profit
926888
Annuals > 3 > income Statement > operating Expenses
34812957
Annuals > 3 > income Statement > operating Income
-33886069
Annuals > 3 > income Statement > interest Expense
201908
Annuals > 3 > income Statement > pretax Income
-33843233
Annuals > 3 > income Statement > net Income
-33535748
Annuals > 3 > income Statement > eps
-1.2741449257279551
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
26320199
Annuals > 3 > income Statement > income Tax Expense
-307485
Annuals > 3 > income Statement > EBITDA
-33726997
Annuals > 3 > income Statement > operating Margin
-1629.1684796013
Annuals > 3 > income Statement > total Other Income Expense Net
42836
Annuals > 3 > balance Sheet > cash
74888145
Annuals > 3 > balance Sheet > short Term Investments
74311203
Annuals > 3 > balance Sheet > receivables
246040
Annuals > 3 > balance Sheet > inventories
-74311203
Annuals > 3 > balance Sheet > total Current Assets
152333996
Annuals > 3 > balance Sheet > property Plant Equipment
6131421
Annuals > 3 > balance Sheet > total Assets
166704832
Annuals > 3 > balance Sheet > payables
1394340
Annuals > 3 > balance Sheet > short Term Debt
274039
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10724723
Annuals > 3 > balance Sheet > equity
155980109
Annuals > 3 > cash Flow > net Income
-33535748
Annuals > 3 > cash Flow > depreciation
159072
Annuals > 3 > cash Flow > change In Working Capital
900416
Annuals > 3 > cash Flow > cash From Operations
-30850882
Annuals > 3 > cash Flow > capital Expenditures
60786
Annuals > 3 > cash Flow > cash From Investing
-75615967
Annuals > 3 > cash Flow > cash From Financing
144264843
Annuals > 3 > cash Flow > net Change In Cash
37797994
Annuals > 3 > ratios > PE
-1.2741449257279551
Annuals > 3 > ratios > PB
1.2925540675189553
Annuals > 3 > ratios > ROE
-21.500015748802944
Annuals > 3 > ratios > ROA
-20.116842204070007
Annuals > 3 > ratios > FCF
-30911668
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-14.861657502232013
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.377233152580048
Valuation > metrics > PB
1.0762495729163792
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-6.564220199744156
Profitability > metrics > ROA
-6.531975351449508
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.057373623603338086
Risk > metrics > Interest Coverage
-178.5174446946308
Risk > final Score
-654
Risk > verdict
High
Liquidity > metrics > Current Ratio
115.58925275752081
Liquidity > metrics > Quick Ratio
115.58925275752081
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
27.481940165743694
Prev Valuations > 2
33.59639197833598
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-194
Prev Risks > 1
-119
Prev Risks > 2
-365
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:51:49.648Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.376
Earnings History > 0 > eps Difference
0.376
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.38
Earnings History > 1 > eps Estimate
-0.41
Earnings History > 1 > eps Difference
0.03
Earnings History > 1 > surprise Percent
7.3171
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.82
Earnings History > 2 > eps Estimate
-0.42
Earnings History > 2 > eps Difference
-0.4
Earnings History > 2 > surprise Percent
-95.2381
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.44
Earnings History > 3 > eps Estimate
-0.49
Earnings History > 3 > eps Difference
0.05
Earnings History > 3 > surprise Percent
10.2041
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.07
Earnings History > 4 > eps Estimate
-0.45
Earnings History > 4 > eps Difference
-0.62
Earnings History > 4 > surprise Percent
-137.7778
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.49
Earnings History > 5 > eps Estimate
-0.5519
Earnings History > 5 > eps Difference
0.0619
Earnings History > 5 > surprise Percent
11.2158
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.47
Earnings History > 6 > eps Estimate
-0.52
Earnings History > 6 > eps Difference
0.05
Earnings History > 6 > surprise Percent
9.6154
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.49
Earnings History > 7 > eps Estimate
-0.5
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
2
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-01
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.52
Earnings History > 8 > eps Estimate
-0.47
Earnings History > 8 > eps Difference
-0.05
Earnings History > 8 > surprise Percent
-10.6383
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.43
Earnings History > 9 > eps Estimate
-0.49
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
12.2449
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.43
Earnings History > 10 > eps Estimate
-0.53
Earnings History > 10 > eps Difference
0.1
Earnings History > 10 > surprise Percent
18.8679
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.51
Earnings History > 11 > eps Estimate
-0.56
Earnings History > 11 > eps Difference
0.05
Earnings History > 11 > surprise Percent
8.9286
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-06
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.5
Earnings History > 12 > eps Estimate
-0.58
Earnings History > 12 > eps Difference
0.08
Earnings History > 12 > surprise Percent
13.7931
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.49
Earnings History > 13 > eps Estimate
-0.49
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.44
Earnings History > 14 > eps Estimate
-0.52
Earnings History > 14 > eps Difference
0.08
Earnings History > 14 > surprise Percent
15.3846
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.49
Earnings History > 15 > eps Estimate
-0.45
Earnings History > 15 > eps Difference
-0.04
Earnings History > 15 > surprise Percent
-8.8889
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-10
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.42
Earnings History > 16 > eps Estimate
-0.39
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-7.6923
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.47
Earnings History > 17 > eps Estimate
-0.57
Earnings History > 17 > eps Difference
0.1
Earnings History > 17 > surprise Percent
17.5439
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.61
Earnings History > 18 > eps Estimate
-1.44
Earnings History > 18 > eps Difference
-0.17
Earnings History > 18 > surprise Percent
-11.8056
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-02
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.26
Earnings History > 19 > eps Estimate
-1.25
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-0.8
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.2585
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-1.2585
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.6466
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.6466
Earnings History > 21 > surprise Percent
-
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$16.8333
Analyst Picks
Strong Buy
2
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 13.43% of the total shares of Immuneering Corp
1.
Vanguard Group Inc(2.4782%)
since
2025/06/30
2.
Vanguard Total Stock Mkt Idx Inv(1.6582%)
since
2025/07/31
3.
Marshall Wace Asset Management Ltd(1.3456%)
since
2025/06/30
4.
BlackRock Inc(0.9913%)
since
2025/06/30
5.
Fidelity Select Biotechnology(0.8999%)
since
2025/07/31
6.
Vanguard Institutional Extnd Mkt Idx Tr(0.631%)
since
2025/07/31
7.
SOUTHPORT MANAGEMENT, L.L.C.(0.5745%)
since
2025/06/30
8.
Geode Capital Management, LLC(0.5399%)
since
2025/06/30
9.
FMR Inc(0.5182%)
since
2025/06/30
10.
Morgan Stanley - Brokerage Accounts(0.4715%)
since
2025/06/30
11.
HighTower Advisors, LLC(0.3188%)
since
2025/06/30
12.
Fidelity Extended Market Index(0.3184%)
since
2025/07/31
13.
State Street Corp(0.2282%)
since
2025/06/30
14.
Bridgeway Capital Management, LLC(0.2238%)
since
2025/06/30
15.
Extended Equity Market Fund K(0.1806%)
since
2025/06/30
16.
TD Health Sciences - I(0.1769%)
since
2024/12/31
17.
CI Private Wealth LLC(0.1495%)
since
2025/06/30
18.
iShares Micro-Cap ETF(0.1489%)
since
2025/08/31
19.
Millennium Management LLC(0.146%)
since
2025/06/30
20.
Bridgeway Ultra-Small Company Market(0.1169%)
since
2025/06/30
21.
Fidelity Total Market Index(0.111%)
since
2025/07/31
22.
Tidemark LLC(0.1041%)
since
2025/06/30
23.
Fidelity Series Total Market Index(0.0994%)
since
2025/07/31
24.
Northern Trust Corp(0.0932%)
since
2025/06/30
25.
JHFunds2 Health Sciences NAV(0.0795%)
since
2025/01/31
26.
First Manhattan Co. LLC(0.0758%)
since
2025/06/30
27.
Flower City Capital(0.0751%)
since
2025/06/30
28.
Spartan Extended Market Index Pool F(0.0726%)
since
2025/07/31
29.
Cubist Systematic Strategies, LLC(0.0689%)
since
2025/06/30
30.
Bank of America Corp(0.0668%)
since
2025/06/30
31.
XTX Topco Ltd(0.0629%)
since
2025/06/30
32.
Avantis US Small Cap Equity ETF(0.0547%)
since
2025/08/30
33.
Alethea Capital Management, LLC(0.0538%)
since
2025/06/30
34.
Vanguard Balanced Index Inv(0.0473%)
since
2025/07/31
35.
NT Ext Equity Mkt Idx Fd - L(0.0445%)
since
2025/06/30
36.
Northern Trust Extended Eq Market Idx(0.0445%)
since
2025/06/30
37.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0414%)
since
2024/12/31
38.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.0414%)
since
2025/07/31
39.
NT Ext Equity Mkt Idx Fd - NL(0.0396%)
since
2025/06/30
40.
Spartan Total Market Index Pool G(0.0394%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.376
Date
2025-09-30
EPS Actual
-0.38
EPS Estimate
-0.41
EPS Difference
0.03
Surprise Percent
7.3171%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.